A peptide antigen derived from EGFR T790M is immunogenic in non-small cell lung cancer

Lung cancer is the leading cause of cancer-related deaths worldwide. Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib and erlotinib, have demonstrated marked clinical activity against non-small cell lung cancer (NSCLC) harboring activating epidermal growth f...

Descripción completa

Detalles Bibliográficos
Autores principales: OFUJI, KAZUYA, TADA, YOSHITAKA, YOSHIKAWA, TOSHIAKI, SHIMOMURA, MANAMI, YOSHIMURA, MAYUKO, SAITO, KEIGO, NAKAMOTO, YASUNARI, NAKATSURA, TETSUYA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277252/
https://www.ncbi.nlm.nih.gov/pubmed/25532027
http://dx.doi.org/10.3892/ijo.2014.2787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277252/
https://www.ncbi.nlm.nih.gov/pubmed/25532027
http://dx.doi.org/10.3892/ijo.2014.2787

Ejemplares similares